BWP
BNTX icon

Baldwin Wealth Partners’s BioNTech BNTX Stock Holding History

Baldwin Wealth Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-651
Closed -$70.7K – 731
2023
Q3 		$70.7K Hold
651
– – 0.01% 347
2023
Q2 		$70.3K Buy
651
+8
+1% +$900 0.01% 369
2023
Q1 		$80.1K Sell
643
-5
-0.8% -$687 0.01% 352
2022
Q4 		$97.3K Buy
648
+164
+34% +$25.2K 0.01% 320
2022
Q3 		$65K Hold
484
– – 0.01% 291
2022
Q2 		$72K Sell
484
-28
-5% -$4.28K 0.01% 294
2022
Q1 		$87K Buy
512
+16
+3% +$2.69K 0.01% 287
2021
Q4 		$128K Buy
+496
New +$136K 0.01% 238

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Baldwin Wealth Partners's BNTX Position: Q4 2023 in Review

Baldwin Wealth Partners sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 651 shares — an estimated $70.7K sold.

Baldwin Wealth Partners first reported a position in BNTX in Q4 2021 and held it in 8 quarters. The position peaked at $128K in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Baldwin Wealth Partners reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Baldwin Wealth Partners sold 651 BioNTech shares in Q4 2023, an estimated $70.7K.
  • Baldwin Wealth Partners first reported a position in BioNTech in Q4 2021 and held it in 8 quarters.
  • Baldwin Wealth Partners's BioNTech position peaked at $128K in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Baldwin Wealth Partners's 13F filing for Q4 2023, filed 8 Jan 2024.